tiprankstipranks
Advertisement
Advertisement

DYN Stock Latest News

Dyne Maintained at Buy as Analyst Reaffirms $50 Price Target on Favorable DM1 Risk‑Reward Outlook
RatingsDyne Maintained at Buy as Analyst Reaffirms $50 Price Target on Favorable DM1 Risk‑Reward Outlook
7d ago
DYN
Dyne Therapeutics price target lowered to $45 from $47 at Morgan Stanley
PremiumThe Fly
Dyne Therapeutics price target lowered to $45 from $47 at Morgan Stanley
24d ago
DYN
Dyne Therapeutics reports Q2 EPS ($1.08), consensus (75c)
PremiumThe Fly
Dyne Therapeutics reports Q2 EPS ($1.08), consensus (75c)
26d ago
DYN
Dyne Therapeutics: Buy Rating Reiterated as FORCE Platform Expands; $47 Price Target Maintained
PremiumRatings
Dyne Therapeutics: Buy Rating Reiterated as FORCE Platform Expands; $47 Price Target Maintained
26d ago
DYN
Dyne Therapeutics receives FDA clearance to initiate DYNE-302 trial
PremiumThe Fly
Dyne Therapeutics receives FDA clearance to initiate DYNE-302 trial
27d ago
DYN
Dyne Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyDyne Therapeutics initiated with an Overweight at Cantor Fitzgerald
1M ago
DYN
Dyne Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Dyne Therapeutics initiated with an Overweight at Cantor Fitzgerald
1M ago
DYN
Dyne Therapeutics Upsized Equity Offering Strengthens Cash Runway
Premium
Company Announcements
Dyne Therapeutics Upsized Equity Offering Strengthens Cash Runway
1M ago
8K
DYN
Midday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
PremiumThe Fly
Midday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
1M ago
T
PM
Dyne Therapeutics 18.3M share Spot Secondary priced at $20.50
PremiumThe Fly
Dyne Therapeutics 18.3M share Spot Secondary priced at $20.50
1M ago
DYN
Closing Bell Movers: Finward jumps after First Financial deal
PremiumThe Fly
Closing Bell Movers: Finward jumps after First Financial deal
1M ago
ALK
DYN
Dyne Therapeutics $300M Spot Secondary; price range $20.00-$21.50
PremiumThe Fly
Dyne Therapeutics $300M Spot Secondary; price range $20.00-$21.50
1M ago
DYN
Dyne Therapeutics announces $300M common stock offering
PremiumThe FlyDyne Therapeutics announces $300M common stock offering
1M ago
DYN
Citi sees intensifying competition for Sarepta from Dyne Therapeutics
Premium
The Fly
Citi sees intensifying competition for Sarepta from Dyne Therapeutics
1M ago
DYN
SRPT
Dyne Therapeutics Advances DYNE-251 With FDA Priority Review
Premium
Company Announcements
Dyne Therapeutics Advances DYNE-251 With FDA Priority Review
1M ago
8K
DYN
Dyne Therapeutics announces FDA acceptance of zeleciment rostudirsen BLA
PremiumThe Fly
Dyne Therapeutics announces FDA acceptance of zeleciment rostudirsen BLA
1M ago
DYN
Dyne Therapeutics initiated with a Buy at TD Cowen
PremiumThe Fly
Dyne Therapeutics initiated with a Buy at TD Cowen
2M ago
DYN
Joseph Thome Initiates Buy on Dyne Therapeutics, Citing Late-Stage Pipeline Strength and Multi-Billion-Dollar Peak Sales Potential
PremiumRatings
Joseph Thome Initiates Buy on Dyne Therapeutics, Citing Late-Stage Pipeline Strength and Multi-Billion-Dollar Peak Sales Potential
2M ago
DYN
Dyne Therapeutics Names Barry Greene Independent Board Director
PremiumCompany Announcements
Dyne Therapeutics Names Barry Greene Independent Board Director
2M ago
8K
DYN
Dyne Therapeutics Expands Hercules Debt Facility for Flexibility
PremiumCompany AnnouncementsDyne Therapeutics Expands Hercules Debt Facility for Flexibility
2M ago
8K
DYN
Dyne Therapeutics Expands Share Authorization After Stockholder Approvals
Premium
Company Announcements
Dyne Therapeutics Expands Share Authorization After Stockholder Approvals
3M ago
8K
DYN
Acting FDA head vows to block political interference, Endpoint News says
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
3M ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >